Lumida
/AUPH
⌘K
Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc

AUPH
$15.96USD+0.13%+0.02 today

MARKET CAP

2.1B

P/E (TTM)

17.7x

FWD P/E

16.1x

DAY RANGE

$16 – $16

52W RANGE

$9
$19

AI Summary

Stalk
Sell NowMedium

Price is in a Stage 1 consolidation following a parabolic collapse, oscillating sideways with compressed volatility and neutral momentum. The active Post-Parabola Collapse pattern implies persistent supply and supports a bearish medium-term bias, despite the underlying long-term uptrend. In the short term, price has rallied into flat-to-declining EMAs and been rejected, offering an immediate signal to sell into resistance. Execution is optimally placed at the 9/21 EMA zone, with rejection-based interaction.

  • Q4 2025 revenue of $77.1M, up 29% YoY
  • 2026 net product sales expected $305M–$315M (+12%–16%)
  • Exclusivity ends January 2026; generic entrants threaten market share
Full analysis →
Loading graphs…